Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1917 of 6351
-
New eye drug shows promise for Diabetes-Related vision loss
Disease control CompletedThis is a multi-centered, open-labeled, single ascending-dose-cohort study to evaluate the safety and efficacy of 4 dose cohorts of AG-73305 administered by intravitreal injection in patients with diabetic macular edema (DME). The objectives of this study were to evaluate the sa…
Phase 2 • Sponsor: Allgenesis Biotherapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
CBD shows promise in curbing opioid cravings
Disease control CompletedThis research aims to determine the effects and safety of cannabidiol (CBD) (ATL5 softgel capsules) as an adjunctive therapy for patients who have Opioid Use Disorder and are taking buprenorphine + naloxone or methadone. Buprenorphine + naloxone and methadone is an approved treat…
Phase 2 • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for hemophilia b: trial tests Long-Acting clotting factor in chinese patients
Disease control CompletedThe study investigates how well the medicine called nonacog beta pegol (N9-GP) works in Chinese people with haemophilia B. Participants will be treated with N9-GP. This is a medicine that doctors can already prescribe in other countries. The medicine will be injected into a vein …
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New drug trial aims to halt Early-Stage blood cancer
Disease control Recruiting nowThis is a single-center, single arm, phase I study designed to determine the safety and find the recommended Phase 2 dose (RP2D) or maximum dose level (MTD) of Belantamab Mafodotin in patients with high-risk smoldering multiple myeloma. The study will have a dose-finding part and…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Simple drug may cut infection risk after major gut surgery
Disease control CompletedThis international, multicentre, pragmatic, double-blind, placebo-controlled, randomised trial of TxA versus placebo will enrol 3,300 patients throughout Australia and internationally. This is an effectiveness trial - some elements of the trial are deliberately left to the periop…
Phase 4 • Sponsor: Bayside Health • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New combo therapy aims to boost red blood cells in MDS patients
Disease control Recruiting nowStudy of the combination of luspatercept in low-risk myelodysplastic syndrom (LR-MDS) without ring sideroblasts (RS) having failed or being ineligible to ESA
Phase 1/2 • Sponsor: Groupe Francophone des Myelodysplasies • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New combo aims to outsmart resistant lung cancer
Disease control Recruiting nowThe purpose of this study is to see if adding pirfenidone to atezolizumab will increase anti tumor activity and reduce treatment resistance in stage 4 and recurrent non- small cell lung cancer participants.
Phase 1/2 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Could freezing dangerous heart plaque stop a heart attack?
Disease control OngoingThe POLARSTAR study is an early safety and feasibility study to evaluate the performance and safety of the CryoTherapy System (CTS) for the treatment of coronary plaque lesions that are not obstructing blood flow but are at high-risk of rupture which would cause a major heart att…
Sponsor: Cryotherapeutics SA • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Zapping cancer during surgery: new rectal cancer trial underway
Disease control OngoingSingle centre double-blinded three-arm randomised controlled trial of extended margin surgery + IOERT at standard dose (10 Gy) versus extended margin surgery + IOERT at higher dose (15 Gy) versus extended margin surgery alone in a 1:1:1 ratio in patients with Locally Advanced Rec…
Sponsor: University Hospital Southampton NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New amputation technique may restore natural limb movement for amputees
Knowledge-focused OngoingThe agonist-antagonist myoneural interface (AMI) construct, known as the Ewing amputation at the trans-tibial level, has been shown to create a bi-directional neural communication platform as a means of controlling and interpreting proprioceptive feedback from a prosthetic joint.…
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC
-
New drug combo aims to control tough cancers in kids and adults
Disease control OngoingImmunotherapies have revolutionized medical oncology following the remarkable and, in some cases, unprecedented outcomes observed in certain groups of patients with cancer. However results in adults and mainly in pediatric cancer are still disappointing. Modulators of angiogenes…
Phase 1/2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Intermittent fasting may cut cancer risk in obesity
Prevention OngoingApproximately 42% of American adults are obese, and this condition is strongly related to the development of colorectal cancer. Innovative lifestyle strategies to treat obesity and reduce colorectal cancer risk are critically needed. This research will demonstrate that time-restr…
Sponsor: University of Illinois at Chicago • Aim: Prevention
Last updated Jul 23, 2026 00:00 UTC
-
New triple-drug combo shows promise for hard-to-treat leukemia patients
Disease control CompletedA study of siremadlin in combination with venetoclax plus azacitidine in adult participants with AML who are ineligible for chemotherapy. The primary purpose of this study was to assess whether siremadlin in combination with venetoclax plus azacitidine can enhance the clinical r…
Phase 1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Virus therapy takes on Platinum-Resistant ovarian cancer
Disease control OngoingThis is an open-label, phase 1/1b, dose-escalation, multicenter and multinational trial evaluating the safety of oncolytic adenovirus TILT-123 in combination with Pembrolizumab, or Pembrolizumab and Pegylated Liposomal Doxorubicin in patients with platinum resistant or refractory…
Phase 1/2 • Sponsor: TILT Biotherapeutics Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Pre-surgery boot camp aims to cut complications in pancreatic cancer patients
Disease control Stopped earlyMajor digestive surgery is associated with a significant rate of postoperative complications. To improve postoperative outcome, efforts are focused on postoperative course leading to the concept of rehabilitation. However, the rehabilitation concept does not allow to improve musc…
Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New hope for lupus nephritis: experimental drug VIB4920 enters Mid-Stage trial
Disease control Recruiting nowThis is a multi-center double-blind placebo controlled clinical trial evaluating the efficacy of VIB4920 combined with mycophenolate mofetil (MMF) and prednisone in achieving a renal response in participants with active lupus nephritis (LN).
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Parent training program aims to ease mental health struggles in foster kids
Symptom relief CompletedThis study capitalizes on an opportunity to formally evaluate local adaptations of "Keeping Foster and Kinship Parents Supported and Trained" (KEEP), an evidence-based foster parent intervention, to reduce mental health disparities among child welfare-involved youth and improve c…
Sponsor: Oregon Social Learning Center • Aim: Symptom relief
Last updated Jun 26, 2026 13:54 UTC
-
Can a natural supplement soothe chemo nerve damage?
Symptom relief OngoingThis phase II trial tests whether PEA works to relieve the symptoms of chemotherapy-induced peripheral neuropathy in patients with cancer. Chemotherapy-induced peripheral neuropathy refers to a nerve problem that causes pain, numbness, tingling, or muscle weakness in different pa…
Phase 2 • Sponsor: Academic and Community Cancer Research United • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
New radiation approach aims to shrink pancreatic tumors in just five sessions
Disease control Recruiting nowThis is an interventional, single-arm, open-label study with high dose short course radiotherapy for patients with locally advanced pancreatic cancer.
Sponsor: EBG MedAustron GmbH • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Talking to kids about weight: 6,600 children test coaching approach to fight obesity
Disease control Recruiting nowPrimary care settings lack interventions to address the childhood obesity epidemic that are feasible and sustainable without requiring significant resources. The investigators propose to modify and test an intervention shown to lower children's body mass index(BMI) so that it is …
Sponsor: Kaiser Permanente • Aim: Disease control
Last updated Jun 26, 2026 14:20 UTC